| N02CD03 |
N02CD03 Fremanezumab |
| N02CD04 |
N02CD04 Ubrogepant |
| N02CD05 |
N02CD05 Eptinezumab |
| N02CD06 |
N02CD06 Rimegepant |
| N02CD07 |
N02CD07 Atogepant |
| N02CD08 |
N02CD08 Zavegepant |
| N02CX |
N02CX Other antimigraine preparations |
| N02CX01 |
N02CX01 pizotifen |
| N02CX02 |
N02CX02 clonidine |
| N02CX03 |
N02CX03 iprazochrome |
| N02CX05 |
N02CX05 dimetotiazine |
| N02CX06 |
N02CX06 oxetorone |
| N02CX07 |
N02CX07 Erenumab |
| N03 |
N03 Antiepileptics |
| N03A |
N03A Antiepileptics |
| N03AA |
N03AA Barbiturates and derivatives |
| N03AA01 |
N03AA01 methylphenobarbital |
| N03AA02 |
N03AA02 phenobarbital |
| N03AA03 |
N03AA03 primidone |
| N03AA04 |
N03AA04 barbexaclone |
| N03AA30 |
N03AA30 metharbital |
| N03AB |
N03AB Hydantoin derivatives |
| N03AB01 |
N03AB01 ethotoin |
| N03AB02 |
N03AB02 phenytoin |
| N03AB03 |
N03AB03 amino(diphenylhydantoin) valeric acid |
| N03AB04 |
N03AB04 mephenytoin |
| N03AB05 |
N03AB05 Fosphenytoin |
| N03AB52 |
N03AB52 phenytoin, combinations |
| N03AB54 |
N03AB54 mephenytoin, combinations |
| N03AC |
N03AC Oxazolidine derivatives |